Persistent erythema and pruritus, with a confluent histiocytic skin infiltrate, following the use of a hydroxyethylstarch plasma expander

British Journal of Dermatology

Volumn 134, Issue 2, 1996, Pages 353-357

  Cox, N H ^a   Popple, A W ^a  

^a CUMBERLAND INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; HETASTARCH; PLASMA SUBSTITUTE; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PRURITUS;

EID: 0030062838     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb07628.x     Document Type: Article

References (15)

1. Parker NE, Porter JB, Williams HJM et al. Pruritus after administration of hetastarch. Br Med 1982; 284: 385-6.
2. Albegger K, Schneeberger R, Franke V et al. Itching following therapy with hydroxyethyl starch (HES) in otoneurological diseases. Wiener Med Wochenschrift 1992; 142: 1-7.
3. Parth E, Jurecka W, Szépfalusi Z, et al. Histological and immunohistochemical investigations of hydroxyethylstarch deposits in rat tissues. Eur Surg Res 1992; 24: 13-21.
4. Jurecka W, Szépfalusi Z, Parth E et al. Hydroxyethylstarch deposits in human skin - a model for pruritus? Arch Dermatol Res 1993; 285: 13-19.
5. Gall H, Kaufmann R, von Ehr M et al. Persistierender pruritus nach hydroxyäthylstärke-infusionen. Retrospektive langzeitstudie an 266 Fällen. Hautarzt 1993; 44: 713-16.
6. Szeimies R-M, Stolz W, Wlottzke U et al. Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 1994; 131: 380-2.
7. Ross EV, Roman L, Rushin JM et al. Xanthomatized atypical T cells in a patient with mycosis fungoides and hyperlipidaemia. Arch Dermatol 1992; 128: 1499-1502.
8. Walker AE, Sneddon IB. Skin xanthoma following erythroderma. Br J Dermatol 1968; 80: 580-7.
9. James MP, Warin AP. Plane xanthoma developing in photosensitive eczema. Clin Exp Dermatol 1982; 3: 307-14.
10. Thivolet J, Leung TK, Duverne J et al. Ultrastructural morphology and histochemistry (acid phosphatase) of the cutaneous infiltration by polyvinylpyrrolidone. Br J Dermatol 1970; 83: 661-9.
11. Fartasch M, Anton-Lamprecht I, Frosch PJ et al. Polyvinylpyrrolidone dermatoses. Clinical aspects and ultrastructural morphology. Hautarzt 1988; 39: 569-75.
12. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; i: 466-9.
13. Szépfalusi Z, Parth E, Jurecka W et al. Human monocytes and keratinocytes in culture ingest hydroxyethylstarch. Arch Dermatol Res 1993; 285: 144-50.
14. Hulse JD, Yacobi A. Hetastarch: an overview of the colloid and its metabolism. Drug Intell Clin Pharm 1983; 17: 334-41.
15. Speight TM (ed). Avery's drug treatment. Principles and Practice of Clinical Pharmacology and Therapeutics, 3rd edn. Edinburgh, Churchill Livingstone, 1987; 33-6.